Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (107663)	7/14/2000 10:41:29 AM
From: Jenna	Respond to of 120523

MYGN was down 20 since I thought it would be a good short opportunity. Unfortunately, this and other biotechs look like there is more correcting down the road. Traders/investors will NOT be interested in moving their money into biotechs when the tech sector is coming out with good earnings. I would rather be long stocks that are expecting good earnings (from 75% to 250% more than last year same quarter) than biotechs that are not earning. For some reason people are usually in denial and don't exit profitable positions even with the writing clearly on the wall.